- Home
- AQST vs STK Comparison
AQST vs STK Comparison
Compare AQST & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- STK
- Stock Information
- Founded
- AQST 2004
- STK 2009
- Country
- AQST United States
- STK United States
- Employees
- AQST N/A
- STK N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- STK Investment Managers
- Sector
- AQST Health Care
- STK Finance
- Exchange
- AQST Nasdaq
- STK Nasdaq
- Market Cap
- AQST 502.6M
- STK 567.0M
- IPO Year
- AQST 2018
- STK N/A
- Fundamental
- Price
- AQST $3.80
- STK $32.80
- Analyst Decision
- AQST Strong Buy
- STK
- Analyst Count
- AQST 8
- STK 0
- Target Price
- AQST $10.38
- STK N/A
- AVG Volume (30 Days)
- AQST 1.5M
- STK 38.2K
- Earning Date
- AQST 11-04-2024
- STK 01-01-0001
- Dividend Yield
- AQST N/A
- STK 6.60%
- EPS Growth
- AQST N/A
- STK N/A
- EPS
- AQST N/A
- STK N/A
- Revenue
- AQST $58,900,000.00
- STK N/A
- Revenue This Year
- AQST $18.45
- STK N/A
- Revenue Next Year
- AQST N/A
- STK N/A
- P/E Ratio
- AQST N/A
- STK N/A
- Revenue Growth
- AQST 22.56
- STK N/A
- 52 Week Low
- AQST $1.84
- STK $24.95
- 52 Week High
- AQST $6.23
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- AQST 36.14
- STK 35.89
- Support Level
- AQST $3.56
- STK $35.35
- Resistance Level
- AQST $3.92
- STK $36.30
- Average True Range (ATR)
- AQST 0.23
- STK 0.49
- MACD
- AQST -0.05
- STK -0.21
- Stochastic Oscillator
- AQST 13.91
- STK 1.32
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.